Filtered By:
Drug: Nicotine
Management: Hospitals
This page shows you your search results in order of date.
Order by Relevance | Date
Total 89 results found since Jan 2013.
Integrated smoking cessation and mood management following acute coronary syndrome: Protocol for the post-acute cardiac event smoking (PACES) trial
DISCUSSION: Results of this study will inform smoking cessation treatments post-ACS and provide unique data on the impact of depressed mood on success of post-ACS health behavior change attempts.TRIAL REGISTRATION: ClinicalTrials.gov, NCT03413423. Registered 29 January 2018. https://beta.CLINICALTRIALS: gov/study/NCT03413423 .PMID:37173792 | PMC:PMC10175930 | DOI:10.1186/s13722-023-00388-9
Source: Addiction Science and Clinical Practice - May 12, 2023 Category: Addiction Authors: Melissa Adkins-Hempel Sandra J Japuntich Michelle Chrastek Shira Dunsiger Christopher E Breault Woubeshet Ayenew Susan A Everson-Rose Prabhjot S Nijjar Beth C Bock Wen-Chih Wu Michael D Miedema Brett M Carlson Andrew M Busch Source Type: research
Career Conversations: Q & A with Bioengineer C ésar de la Fuente
Dr. César de la Fuente. Credit: Martí E. Berenguer.
“Science provides adventure and excitement every single day. When you’re pushing boundaries, you get to jump into the abyss of new areas. It can be scary, but it’s an incredible opportunity to try to improve our world and people’s lives,” says César de la Fuente, Ph.D., a Presidential Assistant Professor in the Perelman School of Medicine and School of Engineering and Applied Science at the University of Pennsylvania, Philadelphia. Our interview with Dr. de la Fuente highlights his journey of becoming a scientist and his research using artificial intelligen...
Source: Biomedical Beat Blog - National Institute of General Medical Sciences - September 21, 2022 Category: Research Authors: Chrissa Chverchko Tags: Being a Scientist Chemistry, Biochemistry and Pharmacology Bacteria Computational Biology Drug Resistance Medicines Profiles Source Type: blogs
CYP2A6 gene polymorphism and severity of coronary atherosclerosis in Indonesian male smokers: A pilot study
Medicine (Baltimore). 2022 Sep 16;101(37):e30308. doi: 10.1097/MD.0000000000030308.ABSTRACTNicotine is a toxic alkaloid known to be responsible for the addictive feature of cigarettes. CYP2A6 genetic polymorphism among individuals was suspected to explain the relationship between cigarette smoking and related diseases. CYP2A6 works to slow nicotine metabolism and thus maintain a more prolonged nicotine concentration and increase nicotine exposure to the blood. We aimed to investigate the correlation between the CYP2A6 gene with the severity of coronary atherosclerosis. This cross-sectional study was conducted from April to...
Source: Atherosclerosis - September 20, 2022 Category: Cardiology Authors: Idar Mappangara Irawan Yusuf Ali Aspar Mappahya Andriany Qanitha Source Type: research
Tobacco product use and the risks of SARS-CoV-2 infection and COVID-19: current understanding and recommendations for future research
Lancet Respir Med. 2022 Aug 16:S2213-2600(22)00182-5. doi: 10.1016/S2213-2600(22)00182-5. Online ahead of print.ABSTRACTHeterogeneity in the clinical presentation of SARS-CoV-2 infection and COVID-19 progression underscores the urgent need to identify individual-level susceptibility factors that affect infection vulnerability and disease severity. Tobacco product use is a potential susceptibility factor. In this Personal View, we provide an overview of the findings of peer-reviewed, published studies relating tobacco product use to SARS-CoV-2 infection and COVID-19 outcomes, with most studies focusing on cigarette smoking ...
Source: Cancer Control - August 19, 2022 Category: Cancer & Oncology Authors: Neal L Benowitz Maciej L Goniewicz Bonnie Halpern-Felsher Suchitra Krishnan-Sarin Pamela M Ling Richard J O'Connor Mary Ann Pentz Rose Marie Robertson Aruni Bhatnagar Source Type: research
The Virus Hunters Trying to Prevent the Next Pandemic
Nobody saw SARS-CoV-2 coming. In the early days of the pandemic, researchers were scrambling to collect samples from people who had mysteriously developed fevers, coughs, and breathing problems. Pretty soon, they realized that the disease-causing culprit was a new virus humans hadn’t seen before.
And the world, lacking a coordinated global response, was unprepared. Some countries acted quickly to develop tests for the novel coronavirus, while others with fewer resources were left behind. With a virus oblivious to national borders, and with travel between countries and continents more common than it had been in previo...
Source: TIME: Health - August 1, 2022 Category: Consumer Health News Authors: Alice Park and Video by Andrew D. Johnson Tags: Uncategorized Disease Frontiers of Medicine 2022 healthscienceclimate Source Type: news
Chronic type 2 reaction possibly triggered by an asymptomatic Bartonella henselae infection in a leprosy patient
We presented a case of a 51-year-old man who was admitted presenting with chronic type 2 leprosy reactions. He had a lepromatous form of leprosy that was histologically diagnosed six months after the onset of signs and symptoms compatible with a chronic type 2 reaction. He reported a history of a previous hepatitis B diagnosis. During a 24-month multidrug therapy (MDT), chronic reactions were partially controlled with prednisone and thalidomide. Thirty-three months following the leprosy treatment, he still experienced chronic reactions, and whole bacilli as well as globi were found on a new skin biopsy. Since coinfections ...
Source: Revista do Instituto de Medicina Tropical de Sao Paulo - February 23, 2022 Category: Tropical Medicine Authors: Luciene Silva Dos Santos Marina Rovani Drummond Andrea Fernandes Eloy da Costa Fran ça Maria Helena Postal Pavan Rafael Fantelli Stelini Maria Let ícia Cintra Elemir Macedo de Souza Paulo Eduardo Neves Ferreira Velho Source Type: research
